Therapeutic Mechanisms of Berberine to Improve the Intestinal Barrier Function via Modulating Gut Microbiota, TLR4/NF-κ B/MTORC Pathway and Autophagy in Cats

Abstract

BackgroundInflammatory bowel disease (IBD), a disease that seriously harms human and animal health, has attracted many researchers’ attention because of its complexity and difficulty in treatment. Most research has involved rats and dogs, and very little was cats. We should know that gut microbiota varies significantly from animal to animal. Traditional Chinese Medicine and its monomer component have many advantages compared with antibiotics used in pet clinics. Numerous studies have shown berberine (berberine hydrochloride) therapeutic value for IBD. However, the specific mechanism remains to consider.ResultsWe assessed gut pathology and analyzed fecal bacterial composition using Histological staining and 16S rRNA sequence. Dioctyl sodium sulfosuccinate (DSS) administration destroyed intestinal mucosal structure and changed the diversity of intestinal flora relative to control. RT-PCR and western blot confirmed specific molecular mechanisms that trigger acute inflammation and intestinal mucosal barrier function disruption after DSS treatment. And autophagy inhibition is typical pathogenesis of IBD. Interestingly, berberine ameliorates inflammation during the development of the intestinal by modulating the toll-like receptors 4 (TLR4)/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathway and activating autophagy. Berberine significantly reduces tumor necrosis factor α (TNF-α), interleukin (IL)-6, and IL-1β expression in cats’ serum. Enhancing the antioxidant effect of IBD cats is one of the protective mechanisms of berberine. We demonstrated that berberine repairs intestinal barrier function by activating the mammalian target of rapamycin (mTOR) complex (MTORC), which inhibits autophagy.ConclusionBerberine can restore intestinal microbiota homeostasis and regulate the TLR4/NF-κB pathway, thereby controlling inflammatory responses. We propose a novel mechanism of berberine therapy for IBD, namely, berberine therapy can simultaneously activate MTORC and autophagy to restore intestinal mucosal barrier function in cats, which should be further studied to shed light on berberine to IBD.

Decreased thioredoxin reductase 3 expression promotes nickel‐induced damage to cardiac tissue via activating oxidative stress‐induced apoptosis and inflammation

“…∆∆Ct was calculated as follows: ∆∆Ct = (Ct target gene −Ct reference gene ) test group −(Ct target gene −Ct reference gene ) control group . The PCR procedure was designed as follows: 95°C for 30 s, 35 cycles at 95°C for 15 s, and 60°C for 30 s. The relative abundance of the mRNAs was analyzed using Pfaff 60 …”

“…The PCR procedure was designed as follows: 95 C for 30 s, 35 cycles at 95 C for 15 s, and 60 C for 30 s. The relative abundance of the mRNAs was analyzed using Pfaff. 60…”

Clinical efficacy of weight loss herbal intervention therapy and lifestyle modifications on obesity and its association with distinct gut microbiome: A randomized double-blind phase 2 study

“…Another exciting result in our study was that the abundance of Verrucomicrobia ( Akkermansia muciniphila ) in the W-LHIT treatment group significantly increased from 4.4% to 10.5%. Increasing evidence indicates that berberine (key compound index) target the gut microbiota and reversely modulate the structure and diversity under pathological conditions, thus exerting poly-pharmacological effects ( 18 , 35 ) such as anti-obesity ( 36 ), anti-hyperlipidemia ( 37 ), anti-diabetes ( 38 ).…”

Clostridium butyricum and Bifidobacterium pseudolongum Attenuate the Development of Cardiac Fibrosis in Mice

“…Based on the Kyoto Encyclopedia of Genes and Genomes (KEGG) functional pathways, the functional composition was predicted for each sample using Phylogenetic Investigation of Communities by Reconstruction of Unobserved States 2 (PICRUSt2) ( 78 ). Statistical analyses were conducted with STAMP, and functional differences in orthologs among groups were assessed by a one-way analysis of variance (ANOVA) followed by Tukey-Kramer multiple comparisons ( 74 , 79 , 80 ).…”